In a Common Size Statement, each item is expressed as a percentage of Revenue from operations.
Given:
Step-wise Calculations:
Common Size Statement of Profit and Loss of QLM Ltd.
for the years ended 31st March, 2023 and 2024 (as % of Revenue from Operations)
Particulars | 2022–23 (%) | 2023–24 (%) |
---|---|---|
Revenue from operations (Base) | \( 100.00 \) | \( 100.00 \) |
Cost of revenue from operations | \( 50.00 \) | \( 50.00 \) |
Gross Profit | \( 50.00 \) | \( 50.00 \) |
Other expenses | \( 10.00 \) | \( 10.00 \) |
Net Profit before Tax | \( 40.00 \) | \( 40.00 \) |
Tax (50%) | \( 20.00 \) | \( 20.00 \) |
Net Profit after Tax | \( 20.00 \) | \( 20.00 \) |
Particulars | Amount (₹) |
---|---|
10% Debentures | \( \text{₹}15,00,000 \) |
Current Liabilities | \( \text{₹}2,00,000 \) |
Non-Current Assets | \( \text{₹}25,00,000 \) |
Current Assets | \( \text{₹}7,00,000 \) |
Statement of Profit (in ₹)
Particulars | 2023–24 (₹) | 2022–23 (₹) |
---|---|---|
Revenue from Operations | 40,00,000 | 20,00,000 |
Less: Purchase of Stock-in-Trade | 8,00,000 | 4,00,000 |
Less: Other Expenses | 4,00,000 | 2,00,000 |
Profit Before Tax | 28,00,000 | 14,00,000 |
Less: Tax @ 50% | 14,00,000 | 7,00,000 |
Net Profit After Tax | 14,00,000 | 7,00,000 |
Use the given information to select the amino acid attached to the 3′ end of tRNA during the process of translation, if the coding strand of the structural gene being transcribed has the nucleotide sequence TAC.